PMC:7408073 / 86422-86942
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T483 | 33-38 | Body_part | denotes | blood | http://purl.org/sig/ont/fma/fma9670 |
T484 | 184-200 | Body_part | denotes | surface of cells | http://purl.org/sig/ont/fma/fma67653 |
T485 | 195-200 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T486 | 450-456 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T168 | 33-38 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
T169 | 208-214 | Body_part | denotes | organs | http://purl.obolibrary.org/obo/UBERON_0000062 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
2984 | 42-46 | Gene | denotes | ACE2 | Gene:59272 |
2985 | 165-169 | Gene | denotes | MasR | Gene:116511 |
2986 | 279-289 | Gene | denotes | bradykinin | Gene:3827 |
2987 | 429-433 | Gene | denotes | ACE2 | Gene:59272 |
2988 | 6-14 | Gene | denotes | Ang (1–7 | Gene:284 |
2989 | 309-317 | Species | denotes | patients | Tax:9606 |
2990 | 124-130 | Gene | denotes | Ang II | Gene:24179 |
2991 | 300-308 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T494 | 300-308 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1035 | 33-38 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
T1036 | 33-38 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | blood |
T1037 | 195-200 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T1038 | 208-214 | http://purl.obolibrary.org/obo/UBERON_0003103 | denotes | organs |
T1039 | 434-442 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T1040 | 450-456 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
T1041 | 471-472 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T52995 | 128-130 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T40147 | 258-269 | Chemical | denotes | metabolites | http://purl.obolibrary.org/obo/CHEBI_25212 |
T54329 | 279-289 | Chemical | denotes | bradykinin | http://purl.obolibrary.org/obo/CHEBI_3165 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T154 | 236-257 | http://purl.obolibrary.org/obo/GO_0014863 | denotes | detection of inactive |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T423 | 216-457 | Sentence | denotes | To this regard, the detection of inactive metabolites, such as bradykinin (1–7), in COVID-19 patients and comparison with its concentration in healthy subjects could be the most indicative and reliable markers of ACE2 activity in the plasma. |